Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Pediatric Radiology|January 1, 1988
Pediatric spinal sonography. Part II: Malformations and mass lesionsM Zieger, U Dörr, R D Schulz
Skeletal Radiology|January 1, 1987
Ultrasonography of hip joint effusionsM M Zieger, U Dörr, R D Schulz
Hormone and Metabolic Research. Supplement Series|January 1, 1993
Biodistribution of 111In-pentetreotide and dosimetric considerations with respect to somatostatin receptor expressing tumor burdenH J Adrian, U Dörr, D Bach, et al.
The Clinical Investigator|November 1, 1994
Ectopic ACTH secretion due to a bronchopulmonary carcinoid localized by somatostatin receptor scintigraphyG Iser, M Pfohl, U Dörr, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1993
Diagnostic reliability of somatostatin receptor scintigraphy during continuous treatment with different somatostatin analogsU Dörr, K Wurm, E Höring, et al.
Clinical Endocrinology|January 1, 1995
Somatostatin receptor imaging in persistent medullary thyroid carcinomaK Frank-Raue, H Bihl, U Dörr, et al.
European Urology|January 1, 1995
Successful interferon-alpha 2 a therapy for a patient with acute mumps orchitisU Rüther, S Stilz, E Röhl, et al.
Deutsche Medizinische Wochenschrift (1946)|March 18, 1994
[Somatostatin receptor scintigraphy in the primary diagnosis and follow-up care of gastrinoma]E Höring, U Räth, S Rücker, et al.
European Journal of Nuclear Medicine|May 1, 1993
Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogueU Dörr, U Räth, M L Sautter-Bihl, et al.
Nuclear Medicine Communications|June 1, 1993
The potential value of somatostatin receptor scintigraphy in medullary thyroid carcinomaU Dörr, K Frank-Raue, F Raue, et al.
Pageof 3